Persistent sexual side effects of finasteride: could they be permanent?
- PMID: 22789024
- DOI: 10.1111/j.1743-6109.2012.02846.x
Persistent sexual side effects of finasteride: could they be permanent?
Abstract
Introduction: Finasteride has been associated with sexual side effects that may persist despite discontinuation of the medication. In a clinical series, 20% of subjects with male pattern hair loss reported persistent sexual dysfunction for ≥6 years, suggesting the possibility that the dysfunction may be permanent. These subjects also reported a wide range of symptoms including changes in cognition, ejaculate quality, and genital sensation. Other medications have been associated with irreversible neurological effects, such as phenothiazines with tardive dyskinesias.
Aim: To prospectively study whether the persistent sexual side effects associated with finasteride resolve or endure over time.
Methods: Subjects (N = 54) with persistent sexual side effects associated with finasteride were reassessed after 9-16 months (mean 14 months). All subjects were otherwise healthy young men without any baseline sexual dysfunction, medical conditions, psychiatric conditions, or use of oral prescription medications prior to taking finasteride for male pattern hair loss.
Main outcome measure: Scores from the Arizona Sexual Experience Scale (ASEX).
Results: The participation rate was 81%. At reassessment persistent sexual side effects continued to be present in 96% of subjects. According to the ASEX scores, 89% of subjects met the definition of sexual dysfunction. Neither the length of finasteride use nor the duration of the sexual side effects correlated to changes in scores of sexual dysfunction.
Conclusion: In most men who developed persistent sexual side effects (≥3 months) despite the discontinuation of finasteride, the sexual dysfunction continued for many months or years. Although several rat studies have shown detrimental changes to erectile function caused by 5 alpha reductase inhibitors, the persistent nature of these changes is an area of active research. Prescribers of finasteride and men contemplating its use should be made aware of the potential adverse medication effects.
© 2012 International Society for Sexual Medicine.
Comment in
-
Persistent sexual side effects of finasteride: could they be permanent?J Sex Med. 2013 May;10(5):1441. doi: 10.1111/jsm.12089. Epub 2013 Feb 19. J Sex Med. 2013. PMID: 23421328 No abstract available.
Similar articles
-
Persistent sexual side effects of finasteride for male pattern hair loss.J Sex Med. 2011 Jun;8(6):1747-53. doi: 10.1111/j.1743-6109.2011.02255.x. Epub 2011 Mar 18. J Sex Med. 2011. PMID: 21418145
-
Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects.J Clin Psychiatry. 2012 Sep;73(9):1220-3. doi: 10.4088/JCP.12m07887. Epub 2012 Aug 7. J Clin Psychiatry. 2012. PMID: 22939118
-
Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms.Am J Mens Health. 2015 May;9(3):222-8. doi: 10.1177/1557988314538445. Epub 2014 Jun 13. Am J Mens Health. 2015. PMID: 24928450
-
The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.Curr Urol Rep. 2018 Jun 16;19(8):65. doi: 10.1007/s11934-018-0814-z. Curr Urol Rep. 2018. PMID: 29909472 Review.
-
Post-finasteride syndrome: a surmountable challenge for clinicians.Fertil Steril. 2020 Jan;113(1):21-50. doi: 10.1016/j.fertnstert.2019.11.030. Fertil Steril. 2020. PMID: 32033719 Review.
Cited by
-
Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: a pilot study.Endocr Connect. 2019 Aug 1;8(8):1118-1125. doi: 10.1530/EC-19-0199. Endocr Connect. 2019. PMID: 31272082 Free PMC article.
-
Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases.Int J Risk Saf Med. 2018;29(3-4):125-134. doi: 10.3233/JRS-180744. Int J Risk Saf Med. 2018. PMID: 29733030 Free PMC article.
-
Cell-free fat extract restores hair loss: a novel therapeutic strategy for androgenetic alopecia.Stem Cell Res Ther. 2023 Aug 23;14(1):219. doi: 10.1186/s13287-023-03398-1. Stem Cell Res Ther. 2023. PMID: 37612726 Free PMC article.
-
Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness.Transl Androl Urol. 2016 Apr;5(2):213-9. doi: 10.21037/tau.2016.03.03. Transl Androl Urol. 2016. PMID: 27141449 Free PMC article. Review.
-
Post-finasteride syndrome.An Bras Dermatol. 2020 May-Jun;95(3):271-277. doi: 10.1016/j.abd.2020.02.001. Epub 2020 Mar 25. An Bras Dermatol. 2020. PMID: 32317131 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous